External broker reports(aggregated public sources), CCZ Statton Equities

CCZ Statton Equities

CCZ is a leading Australian stockbroking firm providing stockbroking and wealth generation services to private clients and institutional investors. Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

External broker reports(aggregated public sources)

Equity Bottom-Up

<div>
<ul>
<li>The clinical trials backlog is now $110.5m (+26% pcp), driven by another strong quarter of clinical trial sales of $17.9m (-56% pcp).</li>
<li>The backlog from clinical trials has underpinned Q1'FY23 group revenue of $8.9m (-27% pcp).</li>
<li>The clinical trial segment contributed $7.8m of revenue (-30% pcp), and the healthcare segment remained flat with $1.1m. Delays in revenue are not of concern.</li>
</ul>
</div>
<p><em>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.</em></p>



The clinical trials backlog is now $110.5m (+26% pcp), driven by another strong quarter of clinical trial sales of $17.9m (-56% pcp).
The backlog from clinical trials has underpinned Q1'FY23 group revenue of $8.9m (-27% pcp).
The clinical trial segment contributed $7.8m of revenue (-30% pcp), and the healthcare segment remained flat with $1.1m. Delays in revenue are not of concern.


Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Cogstate - Backlog Builds for Alzheimer's Trials, but Revenue Delayed

Cogstate Ltd

Cogstate - Backlog Builds for Alzheimer's Trials, but Revenue Delayed